- Front Page
- Registrant group for Cetrimonium Bromide (CTAB)
- Registrant group for Reaction mass of C12 trimethylammonium bromide and C14 trimethylammonium bromide
- Registrant group for Tetradonium Bromide
- Why us
- Download & Publications
- Contact us
6th Annual Biologics Manufacturing Asia
The Annual Biologics Manufacturing Asia, 400+ biomanufacturing stakeholders from BIG Pharma, Biopharma, Contract Manufacturing Organisations, Academic & Research Institutes, Regulatory Authorities across Singapore, South Korea, Taiwan, Japan, Australia, India, Indonesia, Malaysia, and China will convene on the best manufacturing practices in order to have access to faster, cheaper and better biologic drugs!
Increase viable CHO cell density by supplementation with recombinant Insulin Human AF
CHO cells are one of the most widely used platforms for the production of biopharmaceuticals. Increased demand for safety and reliability has moved the standard for CHO cell culture media
from Serum to Serum free and further on to chemically defined media. UAB in collaboration with Novo Nordisk Pharmatech (world’s largest supplier of recombinant insulin) has shown
that addition of animal origin free insulin to three leading commercially available off-the-shelf chemically defined media resulted in significant increases in viable cell density. In addition to
this benefit insulin has been proven to aid in the expression of difficult to express proteins.